IFT22
gene geneOn this page
Also known as FLJ14117FLJ13225DKFZp761N0823FAP9CFAP9
Summary
IFT22 (intraflagellar transport 22, HGNC:21895) is a protein-coding gene on chromosome 7q22.1, encoding Intraflagellar transport protein 22 homolog (Q9H7X7). Small GTPase-like component of the intraflagellar transport (IFT) complex B.
Predicted to enable GTPase activity. Predicted to be involved in intracellular protein transport. Part of intraciliary transport particle B.
Source: NCBI Gene 64792 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 36 total
- MANE Select transcript:
NM_022777
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21895 |
| Approved symbol | IFT22 |
| Name | intraflagellar transport 22 |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14117, FLJ13225, DKFZp761N0823, FAP9, CFAP9 |
| Ensembl gene | ENSG00000128581 |
| Ensembl biotype | protein_coding |
| OMIM | 620505 |
| Entrez | 64792 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 5 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000315322, ENST00000422177, ENST00000430911, ENST00000437644, ENST00000440362, ENST00000468833, ENST00000485695, ENST00000495166, ENST00000498704, ENST00000517481, ENST00000621899
RefSeq mRNA: 6 — MANE Select: NM_022777
NM_001130820, NM_001130821, NM_001130822, NM_001287525, NM_001287526, NM_022777
CCDS: CCDS47670, CCDS47671, CCDS5719
Canonical transcript exons
ENST00000315322 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001809756 | 101310914 | 101315282 |
| ENSE00001909958 | 101321671 | 101321812 |
| ENSE00003490265 | 101318124 | 101318213 |
| ENSE00003603155 | 101316340 | 101316542 |
| ENSE00003631224 | 101318956 | 101319032 |
Expression profiles
Bgee: expression breadth ubiquitous, 273 present calls, max score 98.36.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.5783 / max 223.7382, expressed in 1735 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 85332 | 20.5783 | 1735 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 98.36 | gold quality |
| left testis | UBERON:0004533 | 97.06 | gold quality |
| right testis | UBERON:0004534 | 96.73 | gold quality |
| adult organism | UBERON:0007023 | 96.46 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 96.45 | gold quality |
| sperm | CL:0000019 | 96.08 | gold quality |
| right uterine tube | UBERON:0001302 | 95.98 | gold quality |
| male germ cell | CL:0000015 | 95.46 | gold quality |
| testis | UBERON:0000473 | 95.30 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 94.49 | gold quality |
| bronchus | UBERON:0002185 | 94.29 | gold quality |
| caput epididymis | UBERON:0004358 | 94.24 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.22 | gold quality |
| corpus epididymis | UBERON:0004359 | 93.27 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 92.93 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 92.56 | gold quality |
| cingulate cortex | UBERON:0003027 | 92.55 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.31 | gold quality |
| ventricular zone | UBERON:0003053 | 92.20 | gold quality |
| amygdala | UBERON:0001876 | 92.09 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 92.05 | gold quality |
| nasopharynx | UBERON:0001728 | 92.03 | gold quality |
| pituitary gland | UBERON:0000007 | 91.95 | gold quality |
| adenohypophysis | UBERON:0002196 | 91.93 | gold quality |
| caudate nucleus | UBERON:0001873 | 91.85 | gold quality |
| cortical plate | UBERON:0005343 | 91.53 | gold quality |
| putamen | UBERON:0001874 | 91.12 | gold quality |
| islet of Langerhans | UBERON:0000006 | 90.91 | gold quality |
| neocortex | UBERON:0001950 | 90.89 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-1 | yes | 25.85 |
| E-CURD-114 | yes | 11.77 |
| E-MTAB-9388 | yes | 8.02 |
| E-CURD-135 | no | 708.02 |
| E-MTAB-6678 | no | 3.38 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
69 targeting IFT22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-6134 | 99.63 | 65.68 | 1537 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-372-5P | 99.41 | 69.11 | 2299 |
| HSA-MIR-302A-5P | 99.39 | 68.21 | 1913 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ift22 | ENSDARG00000020822 |
| mus_musculus | Ift22 | ENSMUSG00000007987 |
Protein
Protein identifiers
Intraflagellar transport protein 22 homolog — Q9H7X7 (reviewed: Q9H7X7)
Alternative names: Rab-like protein 5
All UniProt accessions (2): Q9H7X7, F8WDY0
UniProt curated annotations — full annotation on UniProt →
Function. Small GTPase-like component of the intraflagellar transport (IFT) complex B.
Subunit / interactions. Component of the IFT complex B, at least composed of IFT20, IFT22, IFT25, IFT27, IFT46, IFT52, TRAF3IP1/IFT54, IFT57, IFT74, IFT80, IFT81, and IFT88. Interacts with IFT88. Interacts with CFAP61.
Subcellular location. Cell projection. Cilium.
Similarity. Belongs to the small GTPase superfamily. Rab family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H7X7-1 | 1 | yes |
| Q9H7X7-2 | 2 | |
| Q9H7X7-3 | 3 |
RefSeq proteins (6): NP_001124292, NP_001124293, NP_001124294, NP_001274454, NP_001274455, NP_073614* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
Pfam: PF08477
UniProt features (7 total): binding site 3, splice variant 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H7X7-F1 | 92.12 | 0.76 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (3): 10–17; 63–67; 123–126
Post-translational modifications (1): 137
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5620924 | Intraflagellar transport |
MSigDB gene sets: 136 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_CILIUM_ORGANIZATION, GOCC_CENTROSOME, GOBP_ORGANELLE_ASSEMBLY, RFX1_02, GOBP_CELL_PROJECTION_ORGANIZATION, TGGAAA_NFAT_Q4_01, GOCC_CILIARY_TIP, GOCC_INTRACILIARY_TRANSPORT_PARTICLE_B, GOCC_INTRACILIARY_TRANSPORT_PARTICLE, GOCC_CILIUM, GOMF_GTPASE_ACTIVITY, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, DODD_NASOPHARYNGEAL_CARCINOMA_DN
GO Biological Process (3): intracellular protein transport (GO:0006886), intraciliary anterograde transport (GO:0035720), cilium assembly (GO:0060271)
GO Molecular Function (3): GTPase activity (GO:0003924), GTP binding (GO:0005525), nucleotide binding (GO:0000166)
GO Cellular Component (7): centrosome (GO:0005813), cilium (GO:0005929), endomembrane system (GO:0012505), intraciliary transport particle A (GO:0030991), intraciliary transport particle B (GO:0030992), ciliary tip (GO:0097542), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Assembly of the 9+0 primary cilium | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intraciliary transport particle | 3 |
| cellular anatomical structure | 3 |
| protein-containing complex | 2 |
| intracellular protein localization | 1 |
| protein transport | 1 |
| intracellular transport | 1 |
| intraciliary transport | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| vacuole | 1 |
| plasma membrane | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
1390 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IFT22 | IFT27 | Q9BW83 | 996 |
| IFT22 | IFT74 | Q96LB3 | 994 |
| IFT22 | IFT25 | Q9Y547 | 993 |
| IFT22 | IFT46 | Q9NQC8 | 992 |
| IFT22 | IFT81 | Q8WYA0 | 990 |
| IFT22 | IFT52 | Q9Y366 | 989 |
| IFT22 | IFT70B | Q8N4P2 | 983 |
| IFT22 | IFT54 | Q8TDR0 | 976 |
| IFT22 | IFT57 | Q9NWB7 | 959 |
| IFT22 | IFT20 | Q8IY31 | 945 |
| IFT22 | IFT88 | Q13099 | 916 |
| IFT22 | IFT56 | A0AVF1 | 905 |
| IFT22 | IFT172 | Q9UG01 | 888 |
| IFT22 | IFT38 | Q96AJ1 | 882 |
| IFT22 | IFT80 | Q9P2H3 | 849 |
IntAct
74 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IFT56 | IFT70A | psi-mi:“MI:0914”(association) | 0.790 |
| IFT70A | IFT56 | psi-mi:“MI:0914”(association) | 0.790 |
| IFT70B | IFT56 | psi-mi:“MI:0914”(association) | 0.790 |
| IFT27 | IFT56 | psi-mi:“MI:0914”(association) | 0.690 |
| IFT25 | IFT56 | psi-mi:“MI:0914”(association) | 0.690 |
| IFT22 | IFT56 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT46 | IFT56 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT88 | IFT56 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT57 | IFT56 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT172 | IFT56 | psi-mi:“MI:0914”(association) | 0.590 |
| ARL13B | STK25 | psi-mi:“MI:0914”(association) | 0.530 |
| ODAD3 | CCDC22 | psi-mi:“MI:0914”(association) | 0.530 |
| JPH4 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (78): IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Proximity Label-MS), IFT22 (Proximity Label-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS), IFT22 (Affinity Capture-MS)
ESM2 similar proteins: A2AGL3, A4FUD6, A4IHM6, B0LPN4, E9PZQ0, O35626, O94844, P16960, P51157, P51158, Q12829, Q15413, Q32LJ6, Q32NS2, Q3SWY9, Q3SX43, Q4R4K5, Q5E9J4, Q5F361, Q5FVD6, Q5FVJ7, Q5HYI8, Q5M8K8, Q5R8I6, Q5RCC1, Q5RFI2, Q5XGS8, Q5ZKR4, Q63486, Q66JN8, Q6GPS4, Q6NRC7, Q6TNS7, Q7L523, Q7SXV1, Q7ZUV0, Q80X95, Q8BHL5, Q8K0F1, Q91V93
Diamond homologs: A8HME3, O77683, P52198, P61587, P61588, Q381A3, Q4R4K5, Q567Y6, Q5E9J4, Q5FVJ7, Q5M8K8, Q5R9F4, Q6SA80, Q9DAI2, Q9H7X7, Q9QYM5, Q10133, Q54KM9, P06780
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 53 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Intraflagellar transport | 14 | 82.5× | 2e-22 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| intraciliary anterograde transport | 13 | 240.2× | 2e-27 |
| intraciliary transport | 11 | 128.7× | 3e-19 |
| negative regulation of keratinocyte proliferation | 5 | 73.1× | 4e-07 |
| keratinocyte proliferation | 5 | 60.5× | 1e-06 |
| non-motile cilium assembly | 8 | 48.4× | 4e-10 |
| smoothened signaling pathway | 10 | 37.8× | 1e-11 |
| heart looping | 5 | 27.9× | 5e-05 |
| cilium assembly | 16 | 24.5× | 2e-16 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 32 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
621 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:101315281:CGCT:C | acceptor_gain | 1.0000 |
| 7:101315284:T:C | acceptor_gain | 1.0000 |
| 7:101315284:T:TC | acceptor_gain | 1.0000 |
| 7:101316333:T:A | donor_gain | 1.0000 |
| 7:101316338:A:AC | donor_gain | 1.0000 |
| 7:101316339:C:CC | donor_gain | 1.0000 |
| 7:101316339:CA:C | donor_gain | 1.0000 |
| 7:101316353:T:TA | donor_gain | 1.0000 |
| 7:101316399:CA:C | donor_gain | 1.0000 |
| 7:101316408:T:TA | donor_gain | 1.0000 |
| 7:101316460:T:TA | donor_gain | 1.0000 |
| 7:101316538:CAAAC:C | acceptor_gain | 1.0000 |
| 7:101316539:AAAC:A | acceptor_gain | 1.0000 |
| 7:101316540:AAC:A | acceptor_gain | 1.0000 |
| 7:101316541:AC:A | acceptor_gain | 1.0000 |
| 7:101316542:CC:C | acceptor_gain | 1.0000 |
| 7:101316542:CCTG:C | acceptor_loss | 1.0000 |
| 7:101316543:C:CA | acceptor_loss | 1.0000 |
| 7:101316543:C:CC | acceptor_gain | 1.0000 |
| 7:101318122:A:AC | donor_gain | 1.0000 |
| 7:101318123:C:CC | donor_gain | 1.0000 |
| 7:101318126:A:AC | donor_gain | 1.0000 |
| 7:101318126:AGCAT:A | donor_gain | 1.0000 |
| 7:101318127:G:C | donor_gain | 1.0000 |
| 7:101321666:CTTA:C | donor_loss | 1.0000 |
| 7:101321667:TTA:T | donor_loss | 1.0000 |
| 7:101321668:TAC:T | donor_loss | 1.0000 |
| 7:101321669:A:AC | donor_gain | 1.0000 |
| 7:101321669:A:C | donor_loss | 1.0000 |
| 7:101321669:AC:A | donor_gain | 1.0000 |
AlphaMissense
1241 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:101318146:A:G | W62R | 0.999 |
| 7:101318146:A:T | W62R | 0.999 |
| 7:101321682:C:G | G10R | 0.999 |
| 7:101321682:C:T | G10R | 0.999 |
| 7:101318144:C:A | W62C | 0.998 |
| 7:101318144:C:G | W62C | 0.998 |
| 7:101319022:G:A | T17I | 0.998 |
| 7:101321682:C:A | G10W | 0.998 |
| 7:101318143:C:G | D63H | 0.997 |
| 7:101318956:C:A | R39M | 0.997 |
| 7:101319025:T:A | K16I | 0.997 |
| 7:101321681:C:T | G10E | 0.997 |
| 7:101318211:A:G | I40T | 0.996 |
| 7:101318213:C:A | R39S | 0.996 |
| 7:101318213:C:G | R39S | 0.996 |
| 7:101318956:C:G | R39T | 0.996 |
| 7:101316501:C:T | G83E | 0.995 |
| 7:101318142:T:G | D63A | 0.995 |
| 7:101318148:A:G | L61P | 0.995 |
| 7:101318208:A:G | L41P | 0.995 |
| 7:101319013:G:T | A20D | 0.995 |
| 7:101319014:C:G | A20P | 0.995 |
| 7:101319028:C:T | G15E | 0.995 |
| 7:101318142:T:C | D63G | 0.994 |
| 7:101318145:C:G | W62S | 0.994 |
| 7:101318962:C:T | G37E | 0.994 |
| 7:101318142:T:A | D63V | 0.993 |
| 7:101319028:C:A | G15V | 0.993 |
| 7:101318963:C:G | G37R | 0.992 |
| 7:101318963:C:T | G37R | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000320641 (7:101314479 A>G), RS1000394365 (7:101314772 C>G), RS1000400338 (7:101319221 G>C), RS1000618668 (7:101310701 A>G), RS1000628953 (7:101313620 C>G,T), RS1000951520 (7:101310461 C>A,G), RS1001149101 (7:101323164 A>C), RS1001178605 (7:101323521 C>T), RS1001576927 (7:101321552 G>A,C), RS1001605748 (7:101312126 G>A), RS1001633696 (7:101312334 C>G), RS1001975993 (7:101322864 A>C), RS1002219875 (7:101311775 G>A), RS1002365710 (7:101317299 C>T), RS1002396764 (7:101317560 G>A)
Disease associations
OMIM: gene MIM:620505 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007843_12 | Rheumatoid arthritis | 8.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects expression, affects cotreatment | 6 |
| Smoke | increases abundance, increases expression, decreases expression | 2 |
| Tobacco Smoke Pollution | decreases expression | 2 |
| beta-lapachone | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| chromium hexavalent ion | decreases expression, increases abundance | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Demecolcine | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.